TIDMBMK

RNS Number : 2128Q

Benchmark Holdings PLC

16 February 2023

16 February 2023

Benchmark Holdings plc

("Benchmark" or the "Company")

Result of AGM

Benchmark Holdings plc, the aquaculture health, nutrition and genetics business, announces that at the Company's Annual General Meeting, held at 3.00 p.m. today, with the exception of Resolutions 15 and 16, all resolutions were passed by shareholders voting on a poll. The results of the poll are set out below.

 
 Res                             Votes                   Votes                  Votes                    Votes 
  No.      Resolution Name        For             %       Against        %       Total        % I.S.C.    Withheld 
                                              --------                ------- 
  01    Reports and accounts     574,934,271   100.00%         8,379    0.00%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  02    Remuneration Report      572,004,635    99.49%     2,938,015    0.51%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  03    Reappoint Auditors       573,033,919    99.67%     1,908,731    0.33%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  04    Auditors remuneration    574,925,589   100.00%        13,311    0.00%   574,938,900      77.77       5,750 
-----  -----------------------                --------                -------                ---------  ---------- 
  05    Trond Williksen          574,934,271   100.00%         8,379    0.00%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  06    Kristian Eikre           573,072,601    99.67%     1,870,049    0.33%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  07    Septima Maguire          574,934,271   100.00%         8,379    0.00%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  08    Peter George             571,410,678    99.39%     3,521,323    0.61%   574,932,001      77.77      12,649 
-----  -----------------------                --------                -------                ---------  ---------- 
  09    Kevin Quinn              574,934,271   100.00%         8,379    0.00%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  10    Susan Searle             573,072,601    99.67%     1,870,049    0.33%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  11    Yngve Myhre              574,934,271   100.00%         8,379    0.00%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  12    Atle Eide                573,068,851    99.67%     1,870,049    0.33%   574,938,900      77.77       5,750 
-----  -----------------------                --------                -------                ---------  ---------- 
  13    Laura Lavers             573,068,851    99.67%     1,870,049    0.33%   574,938,900      77.77       5,750 
-----  -----------------------                --------                -------                ---------  ---------- 
  14    Allot shares             571,916,971    99.47%     3,025,679    0.53%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  15    pre-emption rights       258,462,999    44.95%   316,479,651   55.05%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
        Additional pre-emption 
  16     rights                  255,447,999    44.43%   319,494,651   55.57%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
  17    Purchase own shares      572,977,997    99.67%     1,898,423    0.33%   574,876,420      77.76      68,230 
-----  -----------------------                --------                -------                ---------  ---------- 
        Cancel share premium 
  18     account                 574,935,897   100.00%         6,753    0.00%   574,942,650      77.77       2,000 
-----  -----------------------                --------                -------                ---------  ---------- 
 

The Board notes that Resolutions 15 (Disapplication of Pre-emption Rights - General) and 16 (Disapplication of Pre-emption Rights - Acquisitions and Specified Capital Investments), which were special resolutions requiring a 75% majority, did not receive sufficient support to be passed.

These resolutions were in line with the updated Pre-Emption Group's Statement of Principles and the Board considers the flexibility afforded by these authorities to be in the best interests of the Company. In accordance with Provision 4 of the UK Corporate Governance Code, the Board confirms that it will consult and continue to engage with the relevant shareholders to understand and discuss their concerns with respect to these resolutions.

Enquiries

 
 For further information, please contact: 
  Benchmark Holdings plc                     Tel: 0114 240 9939 
  Ivonne Cantu, Investor Relations 
 
  Numis (Broker and NOMAD)                   Tel: 020 7260 1000 
  James Black, Freddie Barnfield, Duncan 
   Monteith 
 
  MHP                                        Tel: 020 3128 8004 
  Katie Hunt, Reg Hoare, Veronica Farah      benchmark@mhpgroup.com 
 

About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering mission-critical products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world.

Find out more at www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGUNRWROAUUAAR

(END) Dow Jones Newswires

February 16, 2023 13:03 ET (18:03 GMT)

Benchmark (LSE:BMK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Benchmark Charts.
Benchmark (LSE:BMK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Benchmark Charts.